Novel Potential Approach to Pain Management in Sickle Cell Disease: Arginine Therapy
Introduction Vaso-occlusive episodes (VOEs) remain the primary cause of morbidity in sickle cell disease (SCD), with management heavily reliant on opioid analgesics. Early literature suggests that VOEs may be related to an arginine deficiency. Arginine produces nitric oxide (a potent vasodilator), improves mitochondrial function, and decreases oxidative stress. It is also the precursor for kyotorphin, […]









